drugset / Trial / NCT01627158

Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte

NCT01627158

Phase 1 Completed 72 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.

Timeline

Start
2012-06
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide/formoterol Unknown
Comparator Symbicort Unknown
Background charcoal Unknown

Indications